Metabolism Of Young And Aged Hematopoietic And Acute Myeloid Leukemia Stem Cells: Insights For Rejuvenation And Therapy
Our bodies rely on special cells called hematopoietic stem cells, or HSCs, to continuously produce all types of blood and immune cells throughout our lives. As we age, these vital stem cells undergo changes, including shifts in how they process energy and nutrients, a process known as metabolism. These metabolic alterations can lead to a decline in their function, making us more susceptible to issues like a weakened immune system.
Interestingly, cancer stem cells, specifically those involved in acute myeloid leukemia (AML), also exhibit unique metabolic characteristics that contribute to their ability to initiate the disease and resist treatments. These leukemia stem cells, or LSCs, often have different energy demands and pathways compared to healthy stem cells. For instance, aged HSCs tend to have higher mitochondrial activity and impaired waste removal processes, while LSCs might rely heavily on specific pathways like fatty acid burning to survive and resist chemotherapy.
Understanding these distinct metabolic profiles in both aged healthy stem cells and leukemia stem cells opens up exciting possibilities. Researchers are exploring ways to “rejuvenate” aged healthy stem cells by correcting their metabolic imbalances, potentially restoring their youthful function. Simultaneously, by identifying the metabolic weaknesses of leukemia stem cells, scientists aim to develop new therapies that specifically target and eliminate these dangerous cells without harming healthy ones. This research highlights the potential of metabolic interventions to improve healthy aging and develop more effective cancer treatments.
Source: link to paper